Straight talk: Pfizer translates high science into plain language to make study data easier to readnews2021-07-29T12:55:06+00:00July 29th, 2021|Fierce Pharma|
AstraZeneca’s having second thoughts about its COVID vaccine business as FDA filing drags onnews2021-07-29T10:40:40+00:00July 29th, 2021|Fierce Pharma|
Black women’s group sues J&J over targeted talc marketing—and demands new ads to counteract the oldnews2021-07-28T16:53:24+00:00July 28th, 2021|Fierce Pharma|
FDA warns increased death risk for freshly approved myeloma drug, threatening potential market withdrawalnews2021-07-28T15:55:55+00:00July 28th, 2021|Fierce Pharma|
FDA warns of increased death risk for freshly approved myeloma drug, threatening potential market withdrawalnews2021-07-28T15:55:55+00:00July 28th, 2021|Fierce Pharma|
FDA warns of increased death risk for new myeloma drug, raising prospect of potential market withdrawalnews2021-07-28T15:55:55+00:00July 28th, 2021|Fierce Pharma|
Teva ‘optimistic’ opioid settlement could come within year following historic $26B deal with Johnson & Johnson, 3 distributorsnews2021-07-28T15:36:39+00:00July 28th, 2021|Fierce Pharma|
‘New GSK’ shows strength amid investor pressure, but Shingrix still needs to regain its footingnews2021-07-28T15:33:23+00:00July 28th, 2021|Fierce Pharma|
National Resilience forks over $110M for NC manufacturing site in bluebird bio cell therapy partnershipnews2021-07-28T14:59:12+00:00July 28th, 2021|Fierce Pharma|
Bristol Myers hits CAR-T manufacturing bottleneck as Abecma demand outstrips supplynews2021-07-28T14:22:54+00:00July 28th, 2021|Fierce Pharma|
